2m 2m 2m 2m 2m 2m 2m
NEUMORA (NMRA)
NASDAQ
$1.71-$0.04 (-2.57%)
Price as of Jun 03, 2026 6:34 PM EDT- $342.8MMarket Cap
- 135.50%1-Year Change
- BiotechnologyIndustry
NEUMORA (NMRA)
$1.71-$0.04 (-2.57%)
NMRA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.75 | ||
Change | -$0.07 (-3.85%) | ||
Open | $1.83 | ||
High | $1.83 | ||
Low | $1.73 | ||
Previous Close | $1.82 | ||
Volume | 840,490 | ||
30-Day Average Volume | 1,264,513 | ||
1-Week Change | -4.89% | ||
1-Month Change | -28.28% | ||
1-Year Change | 135.50% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 185.3M | ||
Total Assets | $153.9M | ||
Market Cap | $342.8M | ||
Enterprise Value | $308.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$53.5M | ||
Free Cash Flow | -$46.4M | ||
EBIT | -$52.0M | ||
EBITDA | -$52.0M | ||
Net Working Capital | $123.3M | ||
EPS | -$0.30 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -6 | ||
PEG | -0 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue